tiprankstipranks
Trending News
More News >
Haleon PLC (GB:HLN)
LSE:HLN
UK Market
Advertisement

Haleon PLC (HLN) Earnings Dates, Call Summary & Reports

Compare
257 Followers

Earnings Data

Report Date
Feb 26, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.09
Last Year’s EPS
0.04
Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 31, 2025|
% Change Since: 0.48%|
Earnings Call Sentiment|Neutral
The earnings call reflects both positive developments, such as successful innovations, improved gross margins, and strong performance in Oral Health, and significant challenges in North America, particularly with inventory pressures and declines in the Smokers' Health segment. While there are promising strategies and actions in place to address these issues, the current environment presents considerable headwinds.
Company Guidance -
Q4 2025
During the call, Haleon provided guidance on several metrics, highlighting the challenges and opportunities the company faces, particularly in the North American market. Organic sales growth in North America declined by nearly 2% in Q2, contrasting with growth in other regions like EMEA, LatAm, and APAC, which were within the 4% to 6% medium-term guidance. The company attributed this to a challenging consumer environment, inventory pressures, and a shift towards value channels like Dollar and Club stores. Despite these challenges, Haleon anticipates improved performance in North America, with a focus on regaining share in key brands such as Advil and Centrum. The company also reported strong organic profit growth, driven by a 160 basis point improvement in gross margin and robust cash flow. Additionally, A&P spend increased by 130 basis points, focusing on supporting innovation and expanding reach to lower-income consumers. Haleon remains confident in achieving its medium-term guidance, leveraging supply chain productivity to enhance gross margins and reinvest in growth drivers.
Successful Innovation in Key Markets
Haleon has been rolling out successful innovations, particularly in their clinical range, including Nasal Mist on Otrivin and Panadol Dual Action. The company is also focusing on driving growth in India, Central Europe, and China.
Strong Performance in Oral Health
Haleon's Oral Health segment is performing well, with market share gains and strong growth in the U.S., gaining 0.5 share point in the first half.
Improved Gross Margin and Cash Flow
The company reported an improvement in gross margin by 160 basis points and strong cash flow, which has enabled continued investment in A&P and R&D.
Positive Volume Growth in EMEA, LatAm, and APAC
Volume growth accelerated in Q2 for EMEA and LatAm from 0.5% to 1.6% and for Asia Pac from 3.3% to 3.9%.

Haleon PLC (GB:HLN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

GB:HLN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 26, 2026
2025 (Q4)
0.09 / -
0.043
Jul 31, 2025
2025 (Q2)
0.04 / 0.09
0.039135.90% (+0.05)
Feb 27, 2025
2024 (Q4)
0.04 / 0.04
0.054-20.37% (-0.01)
Aug 01, 2024
2024 (Q2)
0.04 / 0.04
0.085-54.12% (-0.05)
Feb 29, 2024
2023 (Q4)
0.05 / 0.05
0.04812.50% (<+0.01)
Aug 02, 2023
2023 (Q2)
0.04 / 0.09
0.035142.86% (+0.05)
Mar 02, 2023
2022 (Q4)
0.05 / 0.05
0.097-50.52% (-0.05)
Sep 20, 2022
2022 (Q2)
0.09 / 0.04
0.053-33.96% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GB:HLN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 31, 2025
362.66p357.30p-1.48%
Feb 27, 2025
388.32p375.46p-3.31%
Aug 01, 2024
341.42p349.62p+2.40%
Feb 29, 2024
302.71p319.59p+5.58%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Haleon PLC (GB:HLN) report earnings?
Haleon PLC (GB:HLN) is schdueled to report earning on Feb 26, 2026, Before Open (Confirmed).
    What is Haleon PLC (GB:HLN) earnings time?
    Haleon PLC (GB:HLN) earnings time is at Feb 26, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Haleon PLC stock?
          The P/E ratio of Haleon PLC is N/A.
            What is GB:HLN EPS forecast?
            GB:HLN EPS forecast for the fiscal quarter 2025 (Q4) is 0.09.
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis